Skip to content
Sign in
Corporate VCBacked 1 network startup

Estech Pharma

Korean pharmaceutical company making strategic biotech investments, including in BILIX (2019 strategic stake and Series A).

South Korea
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
5most often with DS Asset Management

How they invest

Biotech & life sciences strategic investments; network deal BILIX (acute kidney injury drug).

Stage and ticket

Not specified; strategic and Series A participation.

Geography

South Korea (HQ).

What makes them say yes

  • Pharma pipeline synergy
  • Clinical data
  • Inferred: Korean development

Red flags

  • Non-pharma
  • Unknown

Sectors

  • Biotech & life sciences

Stages

Not published

Geographies

Not published

How to approach

Approach via BILIX with a licensing/partnering angle.

Portfolio

1 network startup · no other company

BILIX strategic investment (2019) and Series A.

Gaps in the portfolio

  • No other Korean biotech in the network

Network startups

  • BILIXSWC 2026 Finalist

    KAIST spin-off developing PEGylated bilirubin BX-001N to prevent acute kidney injury after cardiac surgery, now in phase 2a in Korea.

    South Korea · Biotech & life sciences

Network startups that fit

3 analysed

HKUST polymer-therapeutics platform entering the clinic in dry eye, with osteoarthritis and aesthetics as follow-on indications.

Polymer therapeutics (ophthalmology, osteoarthritis) with first-in-human authorisation: pharma partnering candidate.

20%confidence

Evidence from the records

  • “Polymer-based therapeutics (ophthalmology, osteoarthritis, regenerativ”
  • “Series A”
Intro path
BILIX (Estech portfolio)
First step
Explore licensing for Korea.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with DS Asset Management, IBK (Industrial Bank of Korea), and Magnine Investment

Sources

  1. 1thevc.kr/bilix/fundings

Profile compiled from public sources. Unknown fields are left empty rather than estimated.